Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision history now shows a new version, v3.6.4, superseding the previous v3.6.3. This indicates a backend/content update to the page rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-07-28T14:58:53.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.3, signaling a newer version of the study record. This update appears to be a metadata revision rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-30T02:14:58.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended by stating 'No longer looking for participants' and adds sections to help readers read a study record, view common questions, and learn how to join. It also standardizes the Intervention/Treatment heading and notes the new revision version v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-15T22:01:38.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, indicating a new version of the study record. This update does not modify the study text or results shown on the page.
    Difference
    0.0%
    Check dated 2026-06-08T17:46:16.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new CABOSUN trial citation was added to Publications with Revision: v3.5.4, and the prior Erratum entry (Revision: v3.5.3) was removed.
    Difference
    0.1%
    Check dated 2026-05-18T12:57:25.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    The page’s references section now shows an updated CABOSUN trial citation line including the associated erratum entries. The site footer revision/version tag was also updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-27T07:57:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.